tuberculosis

News

MSF calls for J&J to cut price of TB medicine

The humanitarian medical organisation Medecins Sans Frontieres (MSF) has called on Johnson & Johnson to cut the price of its anti-tuberculosis medicine Sirturo (bedaquiline), to not mor

News

Not-for-profit gets tuberculosis drug approved ahead of big ...

The FDA has approved a new drug to treat certain types of multi-drug resistant tuberculosis – but it’s taken a not-for-profit organisation supported by governments and the billionaire phila

R&D

pharmaphorum podcast with IAVI on global health challenges

Addressing global health challenges: the pharmaphorum podcas...

For episode 11 of the pharmaphorum podcast our CEO and founder Dr Paul Tunnah took the helm to record a special roundtable episode in Philadel

News

GSK TB vaccine shows promise, but more trials needed

GlaxoSmithKline’s experimental TB vaccine has shown that it could help prevent the disease, but further research is needed to identify patients with the strongest response.

News